Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
about
The surgical management of the refractory overactive bladder.Drug Insight: biological effects of botulinum toxin A in the lower urinary tract.The effect of spinal cord-injury level on the outcome of neurogenic bladder treatment using OnabotulinumtoxinA.The overactive bladder: review of current pharmacotherapy in adults. Part 2: treatment options in cases refractory to anticholinergics.Neuromodulatory therapies in female pelvic medicine and reconstructive surgery: biological agents.An Evaluation of the Efficacy of Selective Alpha-Blockers in the Treatment of Children with Neurogenic Bladder Dysfunction--Preliminary Findings.Botulinum toxin A in the overactive bladder: current status and future directions.Botulinum toxin injection: a review of injection principles and protocols.The use of botulinum toxin for the treatment of overactive bladder syndromeMultiple sclerosis symptom management.Refractory idiopathic urge urinary incontinence and botulinum A injection.Botulinum toxin: An emerging therapy in female bladder outlet obstruction.Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis.Pharmacotherapy for overactive bladder: minimally invasive treatment -- botulinum toxins.Evaluation and management of outlet obstruction in women without anatomical abnormalities on physical exam or cystoscopy.Technical aspects of botulinum toxin type A injection in the bladder to treat urinary incontinence: reviewing the procedure.Experience with botulinum toxin type A in the treatment of neurogenic detrusor overactivity in clinical practice.Efficacy and duration of response to botulinum neurotoxin A (onabotulinumA) as a treatment for detrusor overactivity in women.Current and potential urological applications of botulinum toxin A.Open-label study evaluating outpatient urethral sphincter injections of onabotulinumtoxinA to treat women with urinary retention due to a primary disorder of sphincter relaxation (Fowler's syndrome).Pharmacologic management of non-neurogenic functional obstruction in women.Urethral Sphincter Injection of Botulinum Toxin A: A Review of Its Application and Outcomes.Intrapouch injections of botulinum toxin type A for the management of unit contractions of a continent urinary diversionTranscutaneously coupled, high-frequency electrical stimulation of the pudendal nerve blocks external urethral sphincter contractions.Efficacy and safety of two administration modes of an intra-detrusor injection of 750 units dysport® (abobotulinumtoxinA) in patients suffering from refractory neurogenic detrusor overactivity (NDO): A randomised placebo-controlled phase IIa study.Intradetrusor onabotulinumtoxinA injections for refractory neurogenic detrusor overactivity incontinence: do we need urodynamic investigation for outcome assessment?Videourodynamic factors predictive of successful onabotulinumtoxinA urethral sphincter injection for neurogenic or non-neurogenic detrusor underactivity.Botulinum toxin therapy: its use for neurological disorders of the autonomic nervous system.
P2860
Q34124059-59E992C5-73D2-4984-B874-00A201AB0CA7Q35057523-AB339D83-8D6D-479B-A800-C07483A815B8Q35898622-65087C78-5D24-4579-A8C9-9F928E08C889Q36428476-7CAA1536-1C1F-49DE-BA3A-1B0468490BE7Q36566845-31976931-EAD6-4308-8807-DF34D1B8F670Q36732526-08F0B8BC-7701-491D-AA40-6B12C5D45B5AQ36741471-A21D4B28-FBED-4DE3-81E7-5D1BF952936FQ36815354-AE8CF356-336B-46C8-9C8F-3D3E9451A8ABQ36830702-2FA9224F-C162-4375-8817-1769965CAF07Q36941918-59B3D702-89B9-4956-AB35-0391A8A3E27DQ37004158-B8AD2EF5-1ED8-4A21-A6DE-693D9BD667BBQ37427255-8DB5F26C-1B9B-48CD-9E5A-0C9466ED9E2EQ37496473-2C8FDC4E-56FF-459B-9034-680B9A64E6F0Q37834654-7EAF2624-3105-452D-ADF6-21BE2BAAFA9BQ38032816-14ED944F-393E-476F-9594-DCB42A013365Q38182708-866D0967-DB5B-497B-8630-43C33DD265AFQ38184544-FF9159A1-214D-4E87-8A67-E635E5DE6FDCQ38545297-1E9A82FD-E83D-463A-9ADD-A86F7ADBB74DQ38564108-9E51116D-EF9B-42F2-BDED-FFC6622E2A8CQ38598939-A7ECFEB8-E99F-4066-BADB-7912FEFA25B0Q38812355-465FEC33-61C5-46BB-9651-238365DBC11BQ39146316-6D470F3F-9D25-48C9-8742-720126199321Q41777701-E6507E8C-B751-4926-8ABE-E6ED57DD2183Q46182994-94C5C07F-A166-46FC-95CC-FB4D5C29DCD7Q47859226-35D34D3D-49C4-48B0-BCE9-DCBA168BDD4CQ47994885-5867FA4E-4F99-4D54-8751-F87CECD083EBQ48197695-AA592E25-6FC7-45EE-AB25-D9C8FE0507BEQ54458418-25214FB4-2E56-4655-80AD-F4D171569B36
P2860
Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Single-institution experience ...... ction into bladder or urethra.
@ast
Single-institution experience ...... ction into bladder or urethra.
@en
type
label
Single-institution experience ...... ction into bladder or urethra.
@ast
Single-institution experience ...... ction into bladder or urethra.
@en
prefLabel
Single-institution experience ...... ction into bladder or urethra.
@ast
Single-institution experience ...... ction into bladder or urethra.
@en
P2093
P1433
P1476
Single-institution experience ...... ction into bladder or urethra.
@en
P2093
Christopher P Smith
Jun Nishiguchi
Margie O'Leary
Michael B Chancellor
Naoki Yoshimura
P356
10.1016/J.UROLOGY.2004.08.016
P407
P577
2005-01-01T00:00:00Z